Metformin Hydrochloride 500 mg + Glimepiride 4 mg Tablet (Glucim-M4)

Metformin HCl 500 mg + Glimepiride 4 mg

Glucim-M4 SR Tablet — Metformin HCl 500 mg + Glimepiride 4 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Metformin HCl 500 mg + Glimepiride 4 mg
Dosage Form Tablet
Pack Type Box
Pack Size 10 x 10 (Blister)
MRP ₹ 850
Therapy Cardiac + Diabetic — Sulphonylurea + biguanide combination (Sustained Release)
Storage Store below 25°C.

WhatsApp EnquiryCall: +919041677932

For chemists, distributors and doctors: Glucim-M4 (metformin hydrochloride 500 mg + glimepiride 4 mg tablet) is available from Trumac Healthcare on a PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000 – work out your margin with the PTR / PTS calculator.

WhatsApp for price list & availability

See the full antidiabetic tablets range – manufacturer, supplier and PCD franchise: SGLT2 and DPP-4 inhibitors, glimepiride, gliclazide, metformin, voglibose and their combinations.

Schedule G: Metformin is listed in Schedule G of the Drugs Rules, 1945, so the pack carries the red-box caution “SCHEDULE G PRESCRIPTION DRUG – CAUTION: It is dangerous to take this preparation except under medical supervision”. Combinations that also contain a Schedule H molecule carry the Rx label too. See the Schedule G drugs list.

About Glucim-M4 SR Tablet

Glucim-M4 SR Tablet contains Metformin HCl 500 mg + Glimepiride 4 mg. The combination of high-dose Metformin and Glimepiride provides robust glycaemic control for type-2 diabetes inadequately managed on lower-strength preparations.

It is indicated for adults with type-2 DM who need glycaemic intensification while still on oral therapy.

Camrut Healthcare manufactures the Glucim-M range under WHO-GMP conditions for PCD pharma franchise across India.

Glucim-M4 का उपयोग (हिंदी में): टाइप 2 डायबिटीज़ (शुगर) की दवा। सभी Trumac दवाओं के उपयोग हिंदी और अंग्रेज़ी में – Trumac Healthcare tablet uses A–Z। दवा हमेशा डॉक्टर की सलाह से ही लें।

Indications

  • Type-2 diabetes uncontrolled on dual oral therapy
  • Patients needing intensified glycaemic control
  • Glycaemic step-up before initiating insulin

Mechanism of Action

Metformin activates AMPK, suppressing hepatic glucose output and improving peripheral insulin sensitivity. Glimepiride closes ATP-sensitive K+ channels on pancreatic beta cells, triggering insulin secretion. The combination addresses both insulin resistance and inadequate insulin secretion.

Dosage & Administration

  • Adults: 1 tablet once daily before breakfast
  • Titrate based on response
  • Swallow whole — do not crush the SR tablet
  • Monitor renal function and HbA1c periodically

Side Effects

  • Hypoglycaemia
  • GI upset (metformin)
  • Weight gain (mild)
  • Metallic taste
  • Lactic acidosis (rare; avoid in renal impairment)

Contraindications & Precautions

  • Type-1 diabetes
  • Diabetic ketoacidosis
  • eGFR < 30 mL/min/1.73m²
  • Severe hepatic impairment
  • Pregnancy and breastfeeding

Storage

Store below 25°C.

Part of our PCD pharma franchise range, available on a monopoly basis – see the cardiac diabetic PCD franchise product list (PDF). See our full tablets PCD pharma franchise. Comparing companies? See the top cardiac diabetic PCD companies compared. No franchise fee; minimum first order ₹25,000 – cost and documents.

PCD Pharma Franchise & Third-Party Manufacturing
Glucim-M4 SR Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

q

a

q

a

q

a

q

a

q

a

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.